| ID |
date |
title |
| 544 |
1/2/2003 |
FDA Issues Warning on Diathermy with DBS
|
| 545 |
1/6/2003 |
Announcement: Neuroacanthocytosis Meeting Report Available
|
| 546 |
1/6/2003 |
MPTP Toxicity Requires Alpha-synuclein
|
| 547 |
1/24/2003 |
PARK7 Gene Identified
|
| 548 |
1/27/2003 |
Characterization of PKAN (Hallervorden-Spatz Syndrome)
|
| 549 |
2/2/2003 |
Spasticity, Dystonia, and Rigidity: Definitions in Pediatric Disorders
|
| 550 |
2/2/2003 |
An Announcement from WE MOVE
|
| 551 |
2/18/2003 |
Congo Red Disrupts Polyglutamine Oligomers, Protects HD Mice
|
| 552 |
2/20/2003 |
Intrathecal Phenol for MS Spasticity
|
| 553 |
2/20/2003 |
Aggregates, Nuclear Localization Are Required for Polyglutamine Toxicity
|
| 554 |
2/21/2003 |
Neuroanatomy of Off-Medication Dyskinesias in PD Transplant Patients
|
| 555 |
2/26/2003 |
WE MOVE Pediatric Treatment Center Database
|
| 556 |
3/10/2003 |
Caffeine and HRT Interact to Affect PD Risk
|
| 557 |
3/24/2003 |
New at WE MOVE: Anatomical Drawings
|
| 558 |
3/24/2003 |
Announcement: WE MOVE at the AAN in Honolulu
|
| 559 |
3/26/2003 |
PSP: Natural History, Diagnostic Imaging
|
| 560 |
3/28/2003 |
Torsin Inhibits Protein Aggregation
|
| 561 |
4/2/2003 |
RLS Quality of Life Reduction is Significant (AAN 2003)
|
| 562 |
4/2/2003 |
Continued Efficacy of Injectable Apomorphine (AAN 2003)
|
| 563 |
4/2/2003 |
Long-Duration Improvement from STN DBS (AAN 2003)
|
| 564 |
4/3/2003 |
Announcement: Updated Dystonia Slide Set Available
|
| 565 |
4/3/2003 |
OCD and ADHD, Not Tics, Predict Quality of Life in Tourette Syndrome (AAN 2003)
|
| 566 |
4/7/2003 |
SiRNA In Cell Models of DYT1 Dystonia, Polyglutamine disease (AAN 2003)
|
| 567 |
4/8/2003 |
Dopamine Agonists for RLS (AAN 2003)
|
| 568 |
4/9/2003 |
Protein Processing in PD (AAN 2003)
|
| 569 |
4/9/2003 |
Tremor-Ataxia Syndrome From Fragile X Premutation (AAN 2003)
|
| 570 |
4/10/2003 |
West Indies PSP Toxin is a Complex I Inhibitor (AAN 2003)
|
| 571 |
4/11/2003 |
Epidemiology of Parkinson’s Disease (AAN 2003)
|
| 572 |
4/11/2003 |
APOE-4 Increases Risk, Lowers Age of Onset of PD (AAN 2003)
|
| 573 |
4/11/2003 |
Treatment of Essential Tremor (AAN 2003)
|
| 574 |
4/14/2003 |
Reduced Risk of Tardive Dyskinesia with Atypical Antipsychotics (AAN 2003)
|
| 576 |
4/14/2003 |
PD Instability Test Often Performed Incorrectly (AAN 2003)
|
| 575 |
4/14/2003 |
Sertraline for PD Depression (AAN 2003)
|
| 577 |
4/17/2003 |
Announcement: FDA Approves DBS for Dystonia
|
| 578 |
5/2/2003 |
Neuroprotection for Parkinson’s Disease (Journal Contents)
|
| 579 |
5/2/2003 |
Update on Movement Disorders (Journal Contents)
|
| 580 |
5/5/2003 |
Parent-to-Parent Discussion Forum on WE MOVE.org
|
| 581 |
5/6/2003 |
COX-2 Activity is Required for Nigral Degeneration
|
| 587 |
5/27/2003 |
Updated Pediatric Information on the WE MOVE Web Site!
|
| 588 |
5/29/2003 |
Dyskinesias Correlate With Loss of Striatal Synaptic Plasticity
|
| 589 |
6/6/2003 |
Partial D3 Receptor Antagonism Reduces Dyskinesias Without Increasing Parkinsonism
|
| 590 |
6/6/2003 |
Prevalence of Dementia, Treatment of Psychosis in PD
|
| 591 |
6/19/2003 |
Branched-Chain Amino Acids for Tardive Dyskinesia
|
| 592 |
6/25/2003 |
FDA Approves Stalevo for PD
|
| 593 |
7/23/2003 |
Announcement: Movement Disorders Virtual University Is Open
|
| 594 |
8/6/2003 |
Exploring Spasticity: A New Awareness Campaign
|
| 595 |
8/16/2003 |
Fipamezole Reduces Levodopa-Induced Dyskinesias in Primates
|
| 596 |
8/23/2003 |
Anticholinergic drugs may increase AD pathology in PD
|
| 597 |
9/3/2003 |
Cycad Neurotoxins Are Biomagnified in Guamanian Bat Used for Feasts
|
| 598 |
9/5/2003 |
Announcement: Quality-of-Life Survey for People with Parkinson’s Disease
|
| 599 |
9/6/2003 |
Ecstasy-PD Connection Erroneous, Finding Retracted
|
| 600 |
9/8/2003 |
Announcement: Quality-of-Life Survey for People with Parkinson’s Disease
|
| 603 |
10/2/2003 |
Drosophila FXTAS Model Confirms RNA Role in Neurodegeneration
|
| 601 |
10/2/2003 |
Drosophila FXTAS Model Confirms RNA Role in Neurodegeneration
|
| 602 |
10/2/2003 |
Drosophila FXTAS Model Confirms RNA Role in Neurodegeneration
|
| 604 |
10/3/2003 |
Drosophila FXTAS Model Confirms RNA Role in Neurodegeneration
|
| 605 |
10/4/2003 |
Announcement: WE MOVE at the AAPM&R Annual Assembly
|
| 606 |
10/9/2003 |
Announcement: New Hope for Parkinson's Program
|
| 608 |
10/14/2003 |
ITB Does Not Reduce Gait Speed in Ambulatory MS Patients (AAPMR 2003)
|
| 607 |
10/14/2003 |
Technical, Functional, and Social Outcomes After BTX Treatment in CP (AAPMR 2003)
|
| 609 |
10/31/2003 |
Alpha-Synuclein Gene Triplication Causes PD in Iowa Kindred
|
| 610 |
11/3/2003 |
PD Survey Results: Non-Motor Symptoms More Disabling Than Motor Symptoms
|
| 611 |
11/13/2003 |
Rotenone Reduces Proteasome Activity (Neuroscience 2003)
|
| 612 |
11/13/2003 |
STN Stimulation Reduces Cognitive Control (Neuroscience 2003)
|
| 613 |
11/14/2003 |
Announcement: PD Pharmacology Slide Update Available
|
| 614 |
11/14/2003 |
Tourette's Syndrome: Genetics, Neuroanatomy (Neuroscience 2003)
|
| 616 |
11/19/2003 |
HD: Histone Deacetylase Inhibitors, Minocycline, CoQ10 (Neuroscience 2003)
|
| 615 |
11/19/2003 |
HD: Pyrimidines in Preclinical Models (Neuroscience 2003)
|
| 617 |
11/20/2003 |
BDNF Promotes Neural Growth in HD Mice (Neuroscience 2003)
|
| 618 |
11/21/2003 |
HD: Elevated Excitotoxins, Role of Apaf-1(Neuroscience 2003)
|
| 620 |
12/1/2003 |
Long-Term Results from GM1 Ganglioside in PD (Neuroscience 2003)
|
| 622 |
12/1/2003 |
The Opioid System in Dyskinesias (Neuroscience 2003)
|
| 621 |
12/1/2003 |
GDNF Infusion in Primates (Neuroscience 2003)
|
| 619 |
12/1/2003 |
PD Transplants: Neuromelanin Production, Dyskinesias (Neuroscience 2003)
|
| 623 |
12/3/2003 |
Announcement: Dystonia Monograph Preview and Online Resources
|
| 624 |
12/10/2003 |
GAD Gene Therapy for PD (Neuroscience 2003)
|
| 625 |
12/13/2003 |
Adenosine A-2A Receptor Antagonists in Parkinson’s Disease (Journal Contents)
|
| 626 |
12/18/2003 |
Announcement: Free Tics and Tourette's Syndrome Slide Sampler
|
